It should also be pointed out that not all mutations associated with the Noonan syndrome and clinically related disorders have a gain-of-function effect, and in particular, Noonan-like syndrome patients with Shoc2 (S2G) mutations manifest defects consistent with the reduced cell proliferation [37]. The gene discussed is SHOC2; the disease is Noonan syndrome.